ALMIQI

Welcome to the Brand page for “ALMIQI”, which is offered here for Pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, or other central nervous system disorders;.

Its status is currently believed to be active. Its class is unavailable. “ALMIQI” is believed to be currently owned by “Bioxcel Therapeutics, Inc.”

Owner:
BIOXCEL THERAPEUTICS, INC.
Owner Details
Description:
Pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, or other central nervous system disorders;
Categories: PHARMACEUTICALS TREATMENT